A genetic test known as chromosomal microarray analysis (CMA) could help identify the cause of sudden infant death syndrome (SIDS) or its counterpart in older children, known as sudden unexplained ...

Explore the booming Chromosomal Microarray Market, projected to grow from USD 1.69 Billion in 2025 to USD 3.32 Billion by 2034, at a 10.2% CAGR. Driven by demand for advanced genetic diagnostics ...

A genetic test known as chromosomal microarray analysis (CMA) can help identify the cause of sudden infant death syndrome (SIDS) and sudden unexplained death in childhood (SUDC), finds a study led ...

Chromosomal microarray analysis (CMA) becomes a proven method and is implemented to detect gains and losses of DNA and absence of heterozygosity across the genome. Next-generation sequencing ...

The findings suggest that chromosomal microarray analysis (CMA), the method that the researchers used in the study, "should be considered in the genetic evaluation of SUDC," Brownstein said.

Microarrays are wonderful tools for seeing global patterns of gene expression under different conditions. Plenty of software exists to make sense of the data, but what if you want to correlate ...

Maternal chromosomal microarray on DNA extracted from lymphocytes was normal. At amniocentesis, fetal chromosomal microarray and fluorescence in situ hybridization of chromosomes 13, 18, 21, X, and Y ...

The Global Chromosomal Microarray Market Size is valued at USD 1.69 Billion in 2025. Worldwide sales of Chromosomal Microarray Market are expected to grow at a significant CAGR of 10.2%, reaching ...

Thermo Fisher Scientific, Inc. TMO recently launched the Applied Biosystems CytoScan HD Accel array — a new chromosomal microarray intended to enhance cytogenetic research lab productivity ...